Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 751 to 775 of about 5895

Previous 25

Website Changes

02/06/2021

GammaTile webinar posted to our video library!

02/04/2021

Musella Foundation awards two brain tumor research grants!

02/02/2021

First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda

02/01/2021

Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy

01/29/2021

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

01/27/2021

Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research

01/27/2021

Learn More About GammaTile® Therapy, Surgically Targeted Radiation Therapy For Brain Tumors, At Patient Education Event On Thursday, February 4

01/26/2021

NEW MAGNETIC RESONANCE IMAGING (MRI) TECHNIQUE UNCOVERS PATHOPHYSIOLOGICAL PROCESS TO HELP EARLY DETECTION OF RECURRENT GLIOBLASTOMA

01/23/2021

Targepeutics Receives Orphan Drug Designation for Lead Drug Targeting Malignant Glioma

01/23/2021

Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database

01/22/2021

The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic

01/21/2021

Brain Cancer Advocate Al Musella Joins Childhood Cancer Foundation Board of Directors

01/16/2021

Body mass index as an independent prognostic factor in glioblastoma

01/12/2021

Mitochondria in Overdrive Linked to Glioblastomas

01/12/2021

There Is New Hope for Those Fighting the Same Cancer That Took John McCain & Ted Kennedy; Using Polio & Immunotherapy to Fight Brain Tumors

01/12/2021

Toxoplasma gondii infection and the risk of adult gliomain two prospective studies

01/08/2021

U of M begins Phase I of first-in-human clinical trial for glioblastoma

01/08/2021

Chimerix places its bets on Oncoceutics` dopamine antagonist for rare brain cancer in quest to salvage its image

01/08/2021

Kintara Therapeutics and Kazia Therapeutics drugs to enter glioblastoma trial

01/06/2021

Daiichi Sankyo Submits Application for Oncolytic Virus Teserpaturev (G47?) for Treatment of Patients with Malignant Glioma in Japan

01/05/2021

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges

01/05/2021

Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours

01/01/2021

Musella Foundation awards three brain tumor research grants and reopens the brain tumor treatments copayment assistance program!

12/31/2020

Musella Foundation Copay Assistance Program is now open!

12/23/2020

Game changing brain surgery treatment gets Health Canada approval

Our privacy / cookie policy has changed.
Click HERE to read it!